清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Appropriateness and complications of androgen deprivation therapy for prostate cancer: Can we do better? A retrospective observational analysis from a referral center

医学 雄激素剥夺疗法 介绍 前列腺癌 药方 队列 回顾性队列研究 癌症 内科学 儿科 妇科 家庭医学 药理学
作者
Marco Oderda,Oscar Bertetto,Giulia Barbera,Giorgio Calleris,Marco Falcone,Claudia Filippini,Alessandro Marquis,Giancarlo Marra,Gabriele Montefusco,Federica Peretti,Paolo Gontero
出处
期刊:Rivista Urologia [SAGE]
卷期号:90 (1): 100-108 被引量:1
标识
DOI:10.1177/03915603221149502
摘要

Introduction: Androgen deprivation therapy (ADT) is the key of medical treatment for advanced prostate cancer (PCa), especially in elderly patients. However, the adherence of ADT prescription to current guidelines is not optimal and must be balanced against possible side effects. Aim of this study was to evaluate the prescriptive appropriateness of ADT and ADT-related adverse events in a referral center for PCa. Methods: Five hundred fifty six patients who received an outpatient prescription for ADT from 2014 to 2018 were retrospectively identified from an administrative database. Only standard ADT was considered, including GnRH agonists, GnRH antagonists, and antiandrogens. Prescriptive appropriateness was defined according to the last European Association of Urology (EAU) guidelines. Our cohort was stratified according to age categories and patient follow-up was updated. Results: Four hundred twenty five patients were available for analysis. Mean age was 80 years; 96.3% of our patients fell in the “elderly” category. There was a predominance of GnRH agonists over the antagonists (84.9% vs 13%). 15.5% of ADTs did not have an appropriate indication according to guidelines. Patient compliance to ADT was evaluated as good in 372 (87.5%) cases. ADT-related complications were detected in 166 (39%) patients: bone, cardiovascular, and other complications were reported in 7.3%, 8.9%, and 19% of patients. Progression of disease was noted in 165 (38.8%) cases during ADT. At last follow-up, 124 (30.1%) patients were deceased. Conclusions: In a referral center, most ADT prescriptions followed EAU guidelines, but a non-negligible proportion still did not fall within these indications, exposing patients to unnecessary side effects. Compliance to ADT was generally good with a predominant use of GnRH agonists. Tolerance to ADT was fair, even if standardized reports were lacking.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
爱静静应助科研通管家采纳,获得10
21秒前
爱静静应助科研通管家采纳,获得10
21秒前
爱静静应助科研通管家采纳,获得20
21秒前
爱静静应助科研通管家采纳,获得30
22秒前
1分钟前
一杯茶发布了新的文献求助10
1分钟前
可爱的函函应助一杯茶采纳,获得10
1分钟前
bukeshuo发布了新的文献求助10
2分钟前
爱静静应助科研通管家采纳,获得10
2分钟前
爱静静应助科研通管家采纳,获得10
2分钟前
爱静静应助科研通管家采纳,获得10
2分钟前
doreen完成签到 ,获得积分10
2分钟前
没时间解释了完成签到 ,获得积分10
2分钟前
JamesPei应助bukeshuo采纳,获得10
3分钟前
zly完成签到 ,获得积分10
4分钟前
爱静静应助科研通管家采纳,获得10
4分钟前
爱静静应助科研通管家采纳,获得10
4分钟前
爱静静应助科研通管家采纳,获得10
4分钟前
爱静静应助科研通管家采纳,获得10
4分钟前
yanice完成签到,获得积分10
4分钟前
胡锦霞完成签到,获得积分10
4分钟前
4分钟前
一杯茶发布了新的文献求助10
5分钟前
5分钟前
xiaoheshan完成签到,获得积分10
5分钟前
xiaoheshan发布了新的文献求助10
5分钟前
爱静静应助科研通管家采纳,获得20
6分钟前
爱静静应助科研通管家采纳,获得10
6分钟前
爱静静应助科研通管家采纳,获得10
6分钟前
慕青应助一杯茶采纳,获得10
6分钟前
清秀的怀蕊完成签到 ,获得积分10
6分钟前
7分钟前
紫熊完成签到,获得积分10
7分钟前
月儿完成签到 ,获得积分10
7分钟前
缪尔岚完成签到,获得积分10
7分钟前
爱静静应助科研通管家采纳,获得10
8分钟前
爱静静应助科研通管家采纳,获得10
8分钟前
爱静静应助科研通管家采纳,获得10
8分钟前
爱静静应助科研通管家采纳,获得10
8分钟前
wxx完成签到 ,获得积分10
9分钟前
高分求助中
Lire en communiste 1000
Ore genesis in the Zambian Copperbelt with particular reference to the northern sector of the Chambishi basin 800
Becoming: An Introduction to Jung's Concept of Individuation 600
Briefe aus Shanghai 1946‒1952 (Dokumente eines Kulturschocks) 500
A new species of Coccus (Homoptera: Coccoidea) from Malawi 500
A new species of Velataspis (Hemiptera Coccoidea Diaspididae) from tea in Assam 500
Актуализированная стратиграфическая схема триасовых отложений Прикаспийского региона. Объяснительная записка 360
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3167202
求助须知:如何正确求助?哪些是违规求助? 2818687
关于积分的说明 7921888
捐赠科研通 2478444
什么是DOI,文献DOI怎么找? 1320323
科研通“疑难数据库(出版商)”最低求助积分说明 632748
版权声明 602438